(Q40155280)

18 September 2017

title

Administration of Brincidofovir and Convalescent Plasma in a Patient With Ebola Virus Disease (English)

1 reference

18 September 2017

main subject

Orthoebolavirus zairense

0 references

1 reference

6

Timothy M Uyeki

1 reference

18 September 2017

5

Ute Stroher

1 reference

18 September 2017

Diana F Florescu

1

1 reference

18 September 2017

Andre C Kalil

2

1 reference

18 September 2017

Angela L Hewlett

3

1 reference

18 September 2017

Amy J Schuh

4

1 reference

18 September 2017

Philip W Smith

7

1 reference

18 September 2017

language of work or name

English

0 references

publication date

19 May 2015

1 reference

Clinical Infectious Diseases

18 September 2017

published in

1 reference

18 September 2017

volume

61

1 reference

18 September 2017

issue

6

1 reference

18 September 2017

page(s)

969-973

1 reference

Studying "secret serums"--toward safe, effective Ebola treatments

18 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV395

Laboratory diagnosis of Ebola hemorrhagic fever during an outbreak in Yambio, Sudan, 2004.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV395

High-throughput molecular detection of hemorrhagic fever virus threats with applications for outbreak settings

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV395

A case of Ebola virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV395

Clinical care of two patients with Ebola virus disease in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV395

Clinical illness and outcomes in patients with Ebola in Sierra Leone

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV395

Ebola virus disease in West Africa--clinical manifestations and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV395

Treatment of Ebola hemorrhagic fever with blood transfusions from convalescent patients. International Scientific and Technical Committee

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV395

Ebola hemorrhagic fever: evaluation of passive immunotherapy in nonhuman primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV395

Evaluation of immune globulin and recombinant interferon-alpha2b for treatment of experimental Ebola virus infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV395

Preparation and use of hyperimmune serum for prophylaxis and therapy of Ebola virus infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV395

Identification of continuous human B-cell epitopes in the VP35, VP40, nucleoprotein and glycoprotein of Ebola virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV395

Profile and persistence of the virus-specific neutralizing humoral immune response in human survivors of Sudan ebolavirus (Gulu).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV395

Profiling the native specific human humoral immune response to Sudan Ebola virus strain Gulu by chemiluminescence enzyme-linked immunosorbent assay.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV395

First pharmacokinetic and safety study in humans of the novel lipid antiviral conjugate CMX001, a broad-spectrum oral drug active against double-stranded DNA viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV395

Development of CMX001 (Brincidofovir) for the treatment of serious diseases or conditions caused by dsDNA viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV395

CMX001 to prevent cytomegalovirus disease in hematopoietic-cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV395

21 January 2018

Identifiers

DOI

10.1093/CID/CIV395

1 reference

18 September 2017

1 reference